oncology

When Breast Cancer Findings Warrant Another Look

Save

The distance between atypia, DCIS, and invasive breast cancer changes everything about treatment, and it is also where pathologists disagree most. A breast cancer second opinion re-reads the biopsy slides, rechecks the stage and receptor status, and reconsiders the plan. Here is what a review actually re-examines, how often it changes the answer, and how to arrange one.

Last updated: July 2026

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

What a breast cancer diagnosis is built from

A breast cancer diagnosis is assembled from several pieces that can each be reviewed independently. A biopsy sample is read under the microscope to decide whether cells are invasive cancer, non-invasive disease, or a borderline change. That tissue is also tested for receptors — estrogen, progesterone, and HER2 — that steer treatment. Imaging stages how far anything has spread. A second opinion is a chance to recheck each layer rather than the headline alone.

The single most consequential distinction is where a finding sits on a spectrum: ordinary tissue, atypia (borderline changes), DCIS (ductal carcinoma in situ, a non-invasive finding), or invasive cancer. Where a biopsy lands on that line determines whether the conversation is about watchful monitoring, a limited procedure, or full cancer treatment.

Where breast pathology genuinely disagrees

Pathologists agree strongly on clear invasive breast cancer and disagree far more on borderline findings — which is the opposite of reassuring, because the borderline findings are where the treatment stakes are highest. In a study of 240 breast biopsy cases read by practicing pathologists against an expert reference, agreement was high for invasive cancer, but only 48% of atypia cases were read concordantly — 17% overinterpreted and 35% underinterpreted 1, with DCIS at about 84%.

Finding on biopsyAgreement with the expert reference
Invasive breast cancerHigh
DCIS (non-invasive)About 84%
Atypia (borderline)About 48%

The takeaway is not that pathology is unreliable — for the clearest cases it is very reliable. It is that a borderline breast finding is precisely the situation a second read is designed for, because a shift between atypia and DCIS, or DCIS and invasive disease, changes the whole plan.

What a full workup at a specialist center changes

A second opinion at a center that reviews breast cancer as a team can change more than a single slide read. When 70 women who had a breast cancer diagnosis sought a second opinion at a National Cancer Institute–designated center with a multidisciplinary breast tumor board, 42.8% had a change in diagnosis after a complete workup, and 22.8% had a newly identified cancer 2.

That figure comes from a small, single-center group, so it is not a promise about any one person. But it captures why a coordinated review matters: at a tumor board, pathology, radiology, surgery, and oncology look at the same case together, and the combined read sometimes finds something a sequence of separate visits would not.

Re-reading the actual slides, not just the report

A second opinion is strongest when the reviewing pathologist gets the actual slides or tissue blocks, not just a copy of the written report. Re-reading the original material is what catches the occasional major error. In a landmark review of 6,171 outside slides re-read at a large referral hospital, a change of major clinical importance — one that altered therapy or prognosis — was found in about 1.4% of cases 3.

That is an uncommon event, not a routine one. But 1.4% of breast cancer diagnoses is a lot of people, and the only way to know whether yours is one of them is to have the slides re-read. Requesting the slides and blocks early is the part of the process that takes the longest, so it is worth starting first.

Re-reading the staging scans

Pathology is not the only thing that can be re-read. Imaging used to stage a cancer can be interpreted differently by a subspecialist. In a study of outside scans re-read by subspecialists, reviewers reached a discordant opinion about whether disease was present in about 13% of examinations, and where the truth was later confirmed, the subspecialist read was correct in roughly 89% 4.

For breast cancer, staging influences whether treatment is local, systemic, or both. A different read of a scan can move a case from one stage to another, which is why a second opinion often includes a fresh look at the imaging alongside the tissue.

The plan can change even when the diagnosis holds

Much of the value of a breast cancer second opinion is in refining treatment, not overturning the diagnosis. Across 120 newly diagnosed cancers, second opinions produced a clinically meaningful change in about 35% of cases, and most of those changes were adjustments to the treatment plan that occurred even when the original diagnosis was confirmed 5.

A confirmed diagnosis is not a wasted second opinion. For breast cancer, the plan holds many decisions — surgery type, the order of treatments, whether systemic therapy is offered, and how receptor results are used — and a second team may sequence them differently for reasons worth hearing before you commit.

Will it offend your doctor, and how to arrange it

Seeking a second opinion is a normal, expected part of cancer care, and most doctors support it; you are also entitled to copies of your records and pathology materials 6. The worry that asking will insult your first physician is common and almost always unfounded — oncologists request second opinions on their own patients routinely.

The mechanics are the same whatever the diagnosis. Gathering the records for a second opinion means collecting the pathology report and, crucially, the slides or blocks; the biopsy and staging images on a disc or through a portal; and your receptor results. The same logic drives a cancer second opinion of any kind — a colon cancer second opinion, a prostate cancer second opinion where Gleason grading can differ, or a gynecologic cancer second opinion — and all of them start with assembling the material a reviewer needs.

Common questions

Often yes, but for a different reason. Pathologists agree strongly on clear invasive cancer, so the diagnosis itself is unlikely to flip. The value shifts to the plan: the type and order of treatment, how receptor results are used, and staging. Many meaningful second-opinion changes happen even when the diagnosis is confirmed.

Borderline findings like atypia and DCIS are exactly where pathologists disagree most, and where a second read matters most. A shift between atypia, DCIS, and invasive cancer changes the whole treatment conversation, so having the actual slides re-read by a breast pathologist is especially reasonable for a borderline result.

Usually by a short window while records and slides are gathered, not by anything that changes the outcome for most breast cancers. If your team feels the timing is urgent, ask directly how much time you have. For most newly diagnosed breast cancer, there is room for a careful review first.

Not necessarily. Slides, blocks, and imaging can be sent for review without the patient traveling, and some academic centers review records remotely. Traveling in person is more useful when surgery is being planned and you want the surgical team to examine you, but the pathology re-read does not require you to be there.

The pathology report plus the actual slides or tissue blocks, the biopsy and staging imaging on a disc or through a portal, your receptor test results, and any prior mammograms for comparison. A current medication list and a short symptom timeline help the reviewing team orient quickly. Requesting the slides is the step to start earliest.

Related

Say it back

How would you explain this to someone you love?

Two or three sentences, just as you’d say it. Gale reflects back what you focused on — a mirror, not a quiz.

Talk to a clinician

Gale can help you find a clinician in your state and request a visit.

Find care →

When to be seen without waiting

  • —A rapidly enlarging breast mass, or skin that becomes red, warm, thick, or dimpled like an orange peel over days
  • —New nipple retraction or bloody nipple discharge
  • —A breast that becomes suddenly swollen, hard, and painful with fever
  • —A firm, fixed lump in the armpit or above the collarbone

These findings need prompt clinical evaluation rather than waiting for a scheduled second opinion; contact your care team quickly, and go to urgent or emergency care if you have fever with a hot, painful breast.

This article is general health information, not medical advice, and does not replace evaluation by a qualified clinician who knows your case. Decisions about breast cancer should be made with your treating physicians.

References

  1. 1.Elmore JG, Longton GM, Carney PA, Geller BM, Onega T, Tosteson ANA, Nelson HD, Pepe MS, Allison KH, Schnitt SJ, O'Malley FP, Weaver DL (2015). Diagnostic Concordance Among Pathologists Interpreting Breast Biopsy Specimens. JAMA. doi:10.1001/jama.2015.1405 ✓Across 240 breast biopsy cases, agreement with an expert reference was high for invasive cancer, 84% for DCIS, and only 48% for atypia (17% overinterpreted, 35% underinterpreted).
  2. 2.Garcia D, Spruill LS, Irshad A, Wood J, Kepecs D, Klauber-DeMore N (2018). The Value of a Second Opinion for Breast Cancer Patients Referred to a National Cancer Institute (NCI)-Designated Cancer Center with a Multidisciplinary Breast Tumor Board. Annals of Surgical Oncology. doi:10.1245/s10434-018-6599-y ✓Of 70 breast cancer patients seeking a second opinion at an NCI-designated center with a multidisciplinary tumor board, 42.8% had a change in diagnosis after complete workup and 22.8% had a newly identified cancer.
  3. 3.Kronz JD, Westra WH, Epstein JI (1999). Mandatory second opinion surgical pathology at a large referral hospital. Cancer. doi:10.1002/(SICI)1097-0142(19991201)86:11<2426::AID-CNCR34>3.0.CO;2-3 ✓In 6,171 second-opinion surgical pathology cases, 1.4% had a changed diagnosis of major clinical importance that altered therapy or prognosis.
  4. 4.Ulaner GA, Mannelli L, Dunphy M (2017). Value of second-opinion review of outside institution PET-CT examinations. Nuclear Medicine Communications. doi:10.1097/MNM.0000000000000647 ✓Subspecialist re-review of 240 outside PET-CT examinations gave a discordant opinion of malignancy in 13%, and where truth was later known the subspecialist read was correct in 25 of 28 (89%).
  5. 5.Lipitz-Snyderman A, et al. (2023). Clinical value of second opinions in oncology: A retrospective review of changes in diagnosis and treatment recommendations. Cancer Medicine. doi:10.1002/cam4.5598 ✓Across 120 newly diagnosed cancers, second opinions produced clinically meaningful changes in about 35% of cases, most of them treatment changes occurring even when the diagnosis was confirmed.
  6. 6.American Cancer Society (2024). Seeking a Second Opinion. American Cancer Society (cancer.org). link ✓Seeking a second opinion is a normal, expected part of cancer care that most doctors support, and patients are entitled to copies of their records and pathology materials.

6 sources, numbered by first appearance. General health information, not medical advice. AI-assisted editorial content — every citation independently verified. Editorial policy

← Back to the health library